TRU-SENTIMENT · DeltaNeutral
MDT Trading Analysis - 10/01/2026 03:49 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
MDT (Medtronic plc) at $86.60. True Sentiment Bearish, delta 40-60 call 7% / put 93%, call $742,677 vs put $10,354,322. RSI 30.4.
- Symbol
- MDT
- Price
- $86.60
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-10-01 15:49:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis — Delta 40-60 Options:The supplied options methodology uses Delta 40–60 options to identify pure directional conviction. The overall signal is Bearish.
Call Volume: $742,677 (6.70%)
Put Volume: $10,354,322 (93.30%)
Total: $11,096,999
- Put dollar volume exceeds call dollar volume by $9,611,645.
- The call/put dollar-volume ratio is approximately 0.07.
- Call contracts: 5,795; put contracts: 20,405.
- Call trades: 21; put trades: 20.
- The high put share appears to reflect directional size and conviction rather than simply a much larger number of trades.
This positioning suggests that market participants expect near-term weakness or downside hedging around MDT. It aligns with the stock trading below its moving averages, the negative MACD configuration, and its position near the lower end of the 30-day range.
Key Statistics: MDT
Fundamental Snapshot
Valuation
| P/E (trailing) | 21.20 |
| EPS (trailing 12 mo) | $4.08 |
| Market cap | $110.77B |
| Shares outstanding | 1,279.1M |
Dividend
| Dividend yield | 3.34% |
| Annual dividend | $2.88 |
| Ex-dividend date | 2026-09-25 |
Risk & range
| Beta | 0.49 |
| 52-week low | $73.31 |
| 52-week high | $106.33 |
| Historical volatility | 21.9% |
Ownership & trading
| Institutional ownership | 59.7% |
| Average daily volume | 11.6M sh |
Reported figures; no analyst estimates.
📈 Analysis
MDT Trading Analysis
Ticker: MDT | Analysis date: October 1, 2026 | Reference price: $86.60
Bearish Short-term oversold conditions
News Headlines & Context:
- Medtronic remains exposed to medical-device demand: Changes in hospital procedure volumes, chronic-care demand, and device replacement cycles can materially affect quarterly results.
- Diabetes-care performance is an important potential catalyst: Updates involving insulin-delivery systems, glucose-monitoring products, or related product launches could influence expectations for MDT.
- Regulatory and reimbursement developments matter: FDA decisions, Medicare reimbursement changes, and healthcare-policy developments can affect product adoption and profitability.
- Quarterly earnings and guidance would be the primary near-term fundamental catalyst: The embedded data does not provide a recent earnings date, earnings release, revenue-growth figures, or updated analyst targets.
News context should be evaluated separately from the supplied market data. The stock is currently below its short- and medium-term moving averages, while options flow is heavily bearish. A constructive business update could therefore create a relief rally, but the current data does not establish a positive fundamental catalyst.
Fundamental Analysis:
| Metric | Value | Interpretation |
|---|---|---|
| Market capitalization | $110.77 billion | Large-cap medical-device company. |
| Trailing EPS | $4.08 | Positive trailing profitability. |
| Trailing P/E | 21.20 | Valuation is not extremely high in isolation, but no peer or sector data was supplied for a direct comparison. |
| Dividend yield | 3.34% | Provides a meaningful income component. |
| Annual dividend rate | $2.88 | Cash-return profile is part of the fundamental support case. |
| Beta | 0.49 | Historically lower sensitivity to broad market movements than high-beta stocks. |
| Historical volatility | 21.95% | Meaningful volatility remains relevant for option pricing. |
| Institutional ownership | 59.71% | Substantial institutional participation. |
| 52-week range | $73.31–$106.33 | The current price is near the lower portion of the annual range. |
- Revenue growth rates and recent revenue trends cannot be assessed from the supplied fundamentals.
- Gross, operating, and net margins cannot be assessed because the dataset reports null for profit margins and related financial statements.
- Trailing EPS of $4.08 and a trailing P/E of 21.20 provide some valuation context, but the absence of forward EPS and growth data prevents a complete forward valuation assessment.
- The reported PEG ratio is null; therefore, no PEG-based comparison with peers is possible.
- Analyst recommendation and mean target price are also unavailable, so there is no embedded analyst-consensus framework to compare with the bearish options positioning.
- Fundamental strengths include the large scale, positive EPS, dividend, low reported beta, and substantial institutional ownership.
- Key fundamental concerns cannot be fully evaluated because debt, cash flow, margins, ROE, and growth fields are unavailable.
The fundamental picture is mixed rather than clearly bullish. MDT has a positive earnings profile, dividend support, and a relatively defensive beta, but the stock’s technical trend is weak. The market currently appears to be prioritizing near-term price deterioration and cautious directional positioning over the stock’s income and established profitability characteristics.
Current Market Position:
The latest intraday close in the supplied minute bars is $86.60 at 15:20. The official current-price field in the indicators is $86.42. MDT opened the two-day minute-bar sample at $86.57 and ended at $86.60, implying limited net change across the supplied intraday period.
The final five bars show a short-term rebound from an intraday low of $86.43 to $86.64, followed by a modest pullback to $86.60. The last five bars also carried substantial volume, including approximately 247,704, 188,110, 234,281, 198,152, and 229,991 shares.
| Reference | Level |
|---|---|
| Latest minute-bar close | $86.60 |
| Indicator reference price | $86.42 |
| Supplied 30-day low | $86.20 |
| Supplied 30-day high | $95.41 |
| 52-week low | $73.31 |
| 52-week high | $106.33 |
Technical Analysis:
Technical Indicators
Moving-average structure
MDT is below all three supplied moving averages:
- Price versus 5-day SMA: approximately 1.44% below.
- Price versus 20-day SMA: approximately 5.02% below.
- Price versus 50-day SMA: approximately 3.71% below.
The moving averages are not aligned bullishly. The 5-day SMA is below the 20-day SMA, and the 50-day SMA is also below the 20-day SMA. This configuration is consistent with a weak intermediate trend, although oversold conditions can produce sharp countertrend rallies.
RSI and MACD
The RSI at 30.44 is near the conventional oversold threshold of 30.00. This signals weak momentum and a heightened possibility of a short-term technical bounce, but it does not by itself confirm a reversal.
MACD is negative at -0.68, below its signal line at -0.54. The negative histogram of -0.14 shows bearish momentum remains active. No bullish MACD crossover is present in the supplied data.
Bollinger Bands and range position
The Bollinger Bands are:
- Lower band: $86.83
- Middle band: $91.17
- Upper band: $95.51
The indicator reference price of $86.42 is below the lower Bollinger Band of $86.83. This is a bearish statistical position and may indicate an extended move, although bandwidth expansion can continue during a strong downtrend.
The supplied 30-day range is $86.20–$95.41. At approximately $86.60, MDT is only about $0.40 above the 30-day low and approximately 9.26% below the 30-day high. Price is therefore concentrated near the bottom of the recent range.
True Sentiment Analysis — Delta 40-60 Options:
The supplied options methodology uses Delta 40–60 options to identify pure directional conviction. The overall signal is Bearish.
Call Volume: $742,677 (6.70%)
Put Volume: $10,354,322 (93.30%)
Total: $11,096,999
- Put dollar volume exceeds call dollar volume by $9,611,645.
- The call/put dollar-volume ratio is approximately 0.07.
- Call contracts: 5,795; put contracts: 20,405.
- Call trades: 21; put trades: 20.
- The high put share appears to reflect directional size and conviction rather than simply a much larger number of trades.
This positioning suggests that market participants expect near-term weakness or downside hedging around MDT. It aligns with the stock trading below its moving averages, the negative MACD configuration, and its position near the lower end of the 30-day range.
Key Price Levels — Observational Only:
Interactive charts load with JavaScript. This text is the crawlable summary.